可切除胰体尾胰导管腺癌患者影像学脾血管受累的预后作用:基于大样本的回顾性分析
回顾性分析234例可切除胰体尾胰导管腺癌患者,将脾动脉和脾静脉受累分级为清晰、贴邻和包绕。脾动脉或脾静脉包绕患者的总生存和无复发生存显著差于清晰者;多因素分析显示脾动脉包绕(HR 1.89)和脾静脉包绕(HR 2.01)均独立与较差总生存相关,并与早期复发相关(OR分别为4.98和3.71)。
要点
- 脾动脉或脾静脉包绕者总生存和无复发生存显著差于血管清晰者。
- 脾动脉包绕独立与较差总生存相关(HR 1.89),并与早期复发相关(OR 4.98)。
- 脾静脉包绕独立与较差总生存相关(HR 2.01),并与早期复发相关(OR 3.71)。
核心结论
- 影像学脾动脉或脾静脉包绕独立降低可切除胰体尾胰导管腺癌患者的总生存,并与早期复发相关。
研究设计与样本
- 回顾性分析234例可切除胰体尾胰导管腺癌患者,脾动脉和脾静脉受累分级为清晰、贴邻和包绕,采用多因素Cox和logistic回归分析总生存预后因素和早期复发危险因素。
关键影像表现/征象
- 94例患者有影像学脾动脉侵犯,其中贴邻47例、包绕47例。
- 123例患者有影像学脾静脉侵犯,其中贴邻69例、包绕54例。
- 脾动脉或脾静脉包绕患者的总生存和无复发生存显著差于脾动脉或脾静脉清晰者(P < 0.001)。
诊断标准与关键数值
- 脾动脉和脾静脉受累影像学分级:清晰、贴邻、包绕。
- 脾动脉包绕与较差总生存独立相关(HR 1.89,P = 0.010),与早期复发独立相关(OR 4.98,P < 0.001)。
- 脾静脉包绕与较差总生存独立相关(HR 2.01,P = 0.001),与早期复发独立相关(OR 3.71,P = 0.002)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Tumors located in the pancreatic body or tail are more likely to invade splenic vessels; however, splenic artery (SpA) or vein (SpV) involvement is not included in the criteria for resectability. We aimed to analyze the prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma (PDAC) of the body and tail.
METHODS: Patients with resetable PDAC were retrospectively reviewed and analyzed. SpA and SpV involvement were graded as clear, abutment and encasement. Multivariate Cox and logistic regression analyses were used to identify prognostic factors for overall survival (OS) and risk factors for early recurrence, respectively.
RESULTS: Of the 234 patients, 94 patients had radiologic SpA invasion, including abutment in 47 patients and encasement in 47 patients, while 123 patients had radiological SpV invasion, including abutment in 69 patients and encasement in 54 patients. Patients with SpA or SpV encasement showed a significantly worse OS and recurrence-free survival than those with SpA or SpV clear (P < 0.001, respectively). In multivariate analysis, both SpA and SpV encasement were independently associated with poor OS (SpA: hazard ratio [HR] 1.89, P = 0.010; SpV: HR 2.01, P = 0.001) and early recurrence (SpA: odds ratio [OR] 4.98, P < 0.001; SpV: OR 3.71, P = 0.002).
CONCLUSION: Radiological SpA or SpV encasement independently decreases OS, and is associated with early recurrence of resectable PDAC of the body/tail.
引用
- Tan Q, Chen C, Wang Z, et al. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population. Eur J Radiol. 2023. PMID: 37421772. doi:10.1016/j.ejrad.2023.110952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。